Live feed
Filing
SC 13G/A
SC 13G/A0001683168-18-000125·Evoke Pharma Inc
Schedule 13G ownership disclosure
EVOKE PHARMA INC
Security class unavailable · CUSIP: 30049G104
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,472,867
- Percent of class
- 9.5600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-18-000125
- Form type
- SC 13G/A
- Filer
- Evoke Pharma Inc
- CIK
- CIK 1403708
- Filed
- Jan 16, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership